Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation.
Hiroyasu
H
Ogawa
Kazuhiro
K
Ikegame
Manabu
M
Kawakami
Akihiro
A
Tsuboi
Eui Ho
EH
Kim
Naoki
N
Hosen
Masaki
M
Murakami
Tatsuya
T
Fujioka
Tomoki
T
Masuda
Yuki
Y
Taniguchi
Satoshi
S
Yoshihara
Toyoshi
T
Tatekawa
Yoshihiro
Y
Oka
Ichiro
I
Kawase
Toshihiro
T
Soma
Yusuke
Y
Oji
D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000188:drug therapy; D020544:Graft vs Leukemia Effect / Q000502:physiology*; D006680:HLA Antigens / Q000276:immunology*; D006239:Haplotypes; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology
D006680:HLA Antigens; D007166:Immunosuppressive Agents